Express News | TransCode Therapeutics Reports Data From First-in-Human Clinical Study Using TTX-MC138
Express News | Transcode Therapeutics:Data Support Belief That Clinical Development of Ttx-Mc138 Has Potential for Clinical Benefit in Patients With Metastatic Cancer
Express News | Transcode Therapeutics Reports Positive Data From First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, Ttx-Mc138
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersSharps Technology (NASDAQ:STSS) shares rose 193.0% to $0.63 during Tuesday's pre-market session. The market value of their outstanding shares is at $9.8 million. Insmed (NASDAQ:INSM) shares mov
12 Health Care Stocks Moving In Monday's Intraday Session
GainersInnovative Eyewear (NASDAQ:LUCY) shares moved upwards by 421.5% to $0.97 during Monday's regular session. The company's market cap stands at $16.9 million. OneMedNet (NASDAQ:ONMD) shares moved
LIDR, HOOK and BCAB Among Mid-day Movers
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersIGM Biosciences (NASDAQ:IGMS) shares increased by 36.6% to $11.49 during Wednesday's regular session. The market value of their outstanding shares is at $678.1 million. Akso Health Group (NASDA
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAkanda (NASDAQ:AKAN) shares increased by 103.8% to $0.27 during Friday's regular session. The company's market cap stands at $8.6 million. NovaBay Pharmaceuticals (AMEX:NBY) shares rose 48.66%
Analysts' Top Healthcare Picks: Mustang Bio (MBIO), TransCode Therapeutics (RNAZ)
Analysts Offer Insights on Healthcare Companies: TransCode Therapeutics (RNAZ) and Nyxoah (NYXH)
Transcode Therapeutics | 10-Q: Quarterly report
FFIE, OGEN and CCLD Among Mid-day Movers
Why TransCode Therapeutics (RNAZ) Stock Is Getting Hammered
TransCode Therapeutics Inc (NASDAQ:RNAZ) shares are trading lower by 40.6% to $0.84 during Monday's session after the company disclosed plans for a potential reverse stock split in an open letter to i
TransCode Therapeutics Earlier Issued Open Letter To Shareholders; Asks Shareholders To Give Co Authorization To Effect A Reverse Stock Split, As A Last Resort Incase The Nasdaq Panel Hearing Recommends Shares To Be Delisted
The Board and Management of TransCode Therapeutics (NASDAQ:RNAZ) today issued the following open letter to shareholders of the Company:The reason for requesting the authority to do the reverse split i
Express News | TransCode Therapeutics Shards Are Trading Lower After the Company Issued an Open Letter to Its Shareholders
Express News | Transcode Therapeutics Inc: We Intend to Appeal Nasdaq Staff Recommendation That Our Shares Be Delisted
Express News | Transcode Therapeutics Inc: Believe Having Our Stock Continue to Be Listed on Nasdaq Capital Market Will Be Valuable in a Number of Ways
TransCode Therapeutics Open Letter to Shareholders
BOSTON, May 13, 2024 (GLOBE NEWSWIRE) -- The Board and Management of TransCode Therapeutics (NASDAQ:RNAZ) today issued the following open letter to shareholders of the Company: Dear Shareholder, As you may have
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersTevogen Bio Holdings (NASDAQ:TVGN) stock rose 55.4% to $1.53 during Monday's pre-market session. The market value of their outstanding shares is at $251.8 million. MiNK Therapeutics (NASDAQ:INK
TransCode Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/16/2024 536.81% HC Wainwright & Co. → $3 Reiterates Buy → Buy 04/03/2024 536.81% HC Wainwright & Co. →
No Data